SEC Investigation Will Meet Any Solicitation To Purchase XOMA At A "Low-Ball" Price.
As some of you may remember, I monitor the trading activity, on a tick by tick basis, for many of the securities that I own. XOMA is one of those securities. The trading activity in XOMA, over the past few sessions is suspect. There was a rapid sharp break in the price from the $ 3 1/4 level to the $2- $2 1/4 level in that time period, and this represented a few trades, in a very weak market. Stock price manipulation is a felony with serious consequences. The SEC has the trading data and resources to bring prosecution in such cases. If a group, or a prospective acquiring company used that tactic to depress the stock price, to purchase another company at an artificially low price, that would most certainly constitute criminal behavior. I would find it very suspect, if prior to the outcome of the Neuprex trials, a low-ball solitation to purchase XOMA surfaced. I think the SEC would feel the same. My point--if anyone is in fact preparing a solicitaion to purchase XOMA, it better be at a fair price. |
